| x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|---|----------------------------------------------------------------------------------------------|

|  ̈ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|--------|-----------------------------------------------------------------------------------------------|

|                                                                                         |   |                                                |
|----------------------------------------------------------------------------------------------|--------|-----------------------------------------------------|
| Nevada                                                                                       |   | 98-0496750                                          |
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |
|                                                                                         |   |
| 120 Wall StreetSuite 2401New York, N.Y.                                                      |   | 10005                                               |
| (Address of principal executive office)                                  |   | (Zip Code)                                          |

|                                                 |   |                                      |         |                                     |         |                                              |
|------------------------------------------------------|--------|-------------------------------------------|--------------|------------------------------------------|--------------|---------------------------------------------------|
| Large accelerated filer    ̈ |   | Accelerated filer    ̈ |    | Non-accelerated filer   o |    | Smaller Reporting Company   x |

----

| PART I           |                                                                                                                                                                                                         |     |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------|
|             |                                                                                                                                                                                                         |     |
| Item 1.     | Financial Statements                                                                                                                                                                                         | 3        |
|             |                                                                                                                                                                                                         |     |
|             | Condensed Consolidated Balance Sheet of Spring Creek Healthcare Systems, Inc. at September 30, 2010 (unaudited) and December 31, 2009                                                                        | 3        |
|             |                                                                                                                                                                                                         |     |
|             | Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2010 and 2009 and for the period from inception (May 11, 2006) to September 30, 2010 (unaudited) | 4        |
|             |                                                                                                                                                                                                         |     |
|             | Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2010 and 2009 and for the period from inception (May 11, 2006) to September 30, 2010 (unaudited)                | 5        |
|             |                                                                                                                                                                                                         |     |
|             | Condensed Consolidated Statement of Stockholders’ Equity for the period from inception (May 11, 2006) to September 30, 2010 (unaudited)                                       | 6        |
|             |                                                                                                                                                                                                         |     |
|             | Notes to Condensed Consolidated Financial Statements (unaudited)                                                                                                                                             | 7        |
|             |                                                                                                                                                                                                         |     |
| Item 2.          | Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                                                                                  | 12       |
|             |                                                                                                                                                                                                         |     |
| Item 3.     | Quantitative and Qualitative Disclosures about Market Risk                                                                                                                                                   | 14       |
|             |                                                                                                                                                                                                         |     |
| Item 4.     | Controls and Procedures                                                                                                                                                                                      | 15       |
|             |                                                                                                                                                                                                         |     |
| PART II          |                                                                                                                                                                                                         | 15  |
|             |                                                                                                                                                                                                         |     |
| Item 1.     | Legal Proceedings                                                                                                                                                                                            | 15       |
|             |                                                                                                                                                                                                         |     |
| Item 1A.         | Risk Factors                                                                                                                                                                                                 |     |
|             |                                                                                                                                                                                                         |     |
| Item 2.     | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                                                  | 15       |
|             |                                                                                                                                                                                                         |     |
| Item 3.          | Defaults Upon Senior Securities                                                                                                                                                                              |     |
|             |                                                                                                                                                                                                         |     |
| Item 4           | (Removed and Reserved)                                                                                                                                                                                       |     |
|             |                                                                                                                                                                                                         |     |
| Item 5.     | Other Information                                                                                                                                                                                            | 15       |
|             |                                                                                                                                                                                                         |     |
| Item 6.     | Exhibits                                                                                                                                                                                                     | 16       |
|             |                                                                                                                                                                                                         |     |
| Signatures  |                                                                                                                                                                                                         | 17       |
|             |                                                                                                                                                                                                         |     |

----

|                                                                    |   |          |       |    |         |   |
|-------------------------------------------------------------------------|--------|---------------|------------|---------|--------------|--------|
|                                                                    |   | September 30, |       |    | December 31, |   |
|                                                                    |   | 2010          |       |    | 2009         |   |
|                                                                    |   | (unaudited)   |       |    |         |   |
| ASSETS                                                                  |   |          |       |    |         |   |
|                                                                    |   |          |       |    |         |   |
| CURRENT ASSETS                                                          |   |          |       |    |         |   |
|                                                                    |   |          |       |    |         |   |
| Cash                                                                    |   | $             | 319        |    |         | $      | 4,187 |   |
| Prepaid expenses                                                        |   |          | 100        |    |         |   | 12,515 |   |
|   Total current assets                                             |   |          | 419        |    |         |   | 16,702 |   |
|                                                                    |   |          |       |    |         |   |   |   |
| Investment in and advances to affiliated companies                      |   |          | 240,000    |    |         |   | 39,945 |   |
| Intangibles - net                                                       |   |          | 352,157    |    |         |   | - |   |
|                                                                    |   |          |       |    |         |   |   |   |
| TOTAL ASSETS                                                            |   | $             | 592,576    |    |         | $      | 56,647 |   |
|                                                                    |   |          |       |    |         |   |   |   |
|  LIABILITIES AND STOCKHOLDERS' DEFICIENCY                          |   |          |       |    |         |   |   |   |
|                                                                    |   |          |       |    |         |   |   |   |
| CURRENT LIABILITIES                                                     |   |          |       |    |         |   |   |   |
| Accounts payable and accrued expenses                                   |   | $             | 263,802    |    |         | $      | 119,013 |   |
| Notes payable - related party - net of discount of $10,000 and $129,000 |   |          | 535,814    |    |         |   | 203,232 |   |
| Notes payable                                                           |   |          | 122,516    |    |         |   | - |   |
|   Total current liabilities                                        |   |          | 922,132    |    |         |   | 322,245 |   |
|                                                                    |   |          |       |    |         |   |   |   |
| Liability for unissued shares                                           |   |          | 106,258    |    |         |   |   |   |
|                                                                    |   |          |       |    |         |   |   |   |
| STOCKHOLDERS' DEFICIENCY                                                |   |          |       |    |         |   |   |   |
| Common stock, par value $.001 per share; 75,000,000                     |   |          |       |    |         |   |   |   |
|    shares authorized and 35,495,000 and 33,730,000       |   |          |       |    |         |   |   |   |
|    issued and outstanding                                |   |          | 35,495     |    |         |   | 33,730 |   |
| Additional paid-in capital                                              |   |          | 4,548,592  |    |         |   | 2,088,307 |   |
| Deferred compensation                                                   |   |          | -          |    |         |   | (9,340 | ) |
| Deficit accumulated during the development stage                        |   |          | (4,899,901 | )       |         |   | (2,378,295 | ) |
| Accumulated other comprehensive loss                                    |   |          | (120,000   | )  |         |   |   |   |
|   Total stockholders' deficiency                                   |   |          | (435,814   | )       |         |   | (265,598 | ) |
|                                                                    |   |          |       |    |         |   |   |   |
| TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIENCY                          |   | $             | 592,576    |    |         | $      | 56,647 |   |

----

|                                                     |   | Three months endedSeptember 30, |       |    | Nine months endedSeptember 30, |   |       | From inception(May 11, 2006)to September 30, |   |
|----------------------------------------------------------|--------|---------------------------------|------------|---------|--------------------------------|--------|------------|----------------------------------------------|--------|
|                                                     |   | 2010                            |       |    | 2009                           |   |       | 2010                                         |   |   | 2009 |   |   | 2010 |   |
|                                                     |   |                            |       |    |                           |   |       |                                         |   |   |   |   |   |   |   |
| General and Administrative                               |   | $                               | 182,130    |    |                           | $      | 71,238     |                                         |   | $ | 2,645,834 |   |   | $ | 153,463 |   |   | $ | 3,187,172 |   |
| Interest                                                 |   |                            | 15,642     |    |                           |   | 5,218      |                                         |   |   | 56,198 |   |   |   | 7,829 |   |   |   | 75,395 |   |
| Amortization of debt discount                            |   |                            | 47,593     |    |                           |   | 59,630     |                                         |   |   | 155,228 |   |   |   | 59,630 |   |   |   | 257,828 |   |
| Finance costs                                            |   |                            | 24,400     |    |                           |   | 528,260    |                                         |   |   | 24,400 |   |   |   | 528,260 |   |   |   | 1,747,400 |   |
| Total expenses                                           |   |                            | 269,765    |    |                           |   | 664,346    |                                         |   |   | 2,881,660 |   |   |   | 749,182 |   |   |   | 5,267,795 |   |
|                                                     |   |                            |       |    |                           |   |       |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Other expense/( income)- related to affiliated companies |   |                            | (359,583   | )  |                           |   | (15,420    | )                                       |   |   | (360,054 | )  |   |   | (15,420 | ) |   |   | (2,851 | ) |
|                                                     |   |                            |       |    |                           |   |       |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Net income (loss)                                        |   | $                               | 89,818     |    |                           | $      | (648,926   | )                                            |   | $ | (2,521,606 | ) |   | $ | (733,762 | ) |   | $ | (5,264,944 | ) |
|                                                     |   |                            |       |    |                           |   |       |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Incom (loss) per share – basic and diluted         |   | $                               | 0.00       |    |                           | $      | (0.02      | )                                            |   | $ | (0.07 | ) |   | $ | (0.02 | ) |   |   |   |   |
|                                                     |   |                            |       |    |                           |   |       |                                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares outstanding                      |   |                            | 35,162,120 |    |                           |   | 33,730,000 |                                         |   |   | 34,463,901 |   |   |   | 33,631,103 |   |   |   |   |   |

----

|                                                                                                                 |   |              |                                  |    |             |   |          | From inception |   |
|----------------------------------------------------------------------------------------------------------------------|--------|-------------------|---------------------------------------|---------|------------------|--------|---------------|----------------|--------|
|                                                                                                                 |   | Nine months ended |                                  |    | (May 11, 2006)   |   |
|                                                                                                                 |   | September 30,     |                                  |    | to September 30, |   |
|                                                                                                                 |   | 2010              |                                  |    | 2009             |   |          |           | 2010   |   |
| Cash Flows Used in Operating Activities                                                                              |   |              |                                  |    |             |   |          |           |   |   |
|   Net Loss                                                                                                      |   | $                 | (2,521,606                            | )       |             | $      | (733,762      | )              |   | $ | (4,899,901 | ) |
|   Adjustments to reconcile net loss to net cash                                                                 |   |              |                                  |    |             |   |          |           |   |   |   |   |
|   used in operating activities:                                                                                 |   |              |                                  |    |             |   |          |           |   |   |   |   |
|   Amortization of debt discount                                                                                 |   |              | 155,228                               |    |             |   | 59,630        |           |   |   | 257,828 |   |
|   Equity in losses of unconsolidated subsidiaries                                                               |   |              | 34,989                                |    |             |   | (36,955       | )         |   |   | 80,150 |   |
|   Gain on exchange in minority interest in BioCube, Inc.                                                        |   |              | (365,043                              | )  |             |   |          |           |   |   | (365,043 | )  |
|   Amortization of deferred compensation                                                                         |   |              | 9,340                                 |    |             |   |          |           |   |   | 13,450 |   |
|   Accrued interest – related party                                                                        |   |              | 52,362                                |    |             |   | 7,904         |           |   |   | 71,559 |   |
|   Accrued interest                                                                                         |   |              | 2,016                                 |    |             |   |          |           |   |   | 2,016 |   |
|   Services - noncash charges                                                                                    |   |              | 2,232,908                             |    |             |   |          |           |   |   | 2,232,908 |   |
|   Accrued fees from affiliates                                                                                  |   |              | (33,658                               | )       |             |   |          |           |   |   | (87,589 | ) |
|   Finance costs                                                                                                 |   |              | 24,400                           |    |             |   | 528,260  |           |   |   | 1,747,400 |   |
|      Changes in operating assets and liabilities:                                           |   |              |                                  |    |             |   |          |           |   |   |   |   |
|              Accounts receivable                    |   |              |                                  |    |             |   | (12,920       | )         |   |   |   |   |
|              Prepaid expenses                       |   |              | 12,415                                |    |             |   | (730)    |           |   |   |         (100 | )  |
|              Accounts payables and accrued expenses |   |              | 163,471                               |    |             |   | 13,624        |           |   |   | 291,337 |   |
| Net Cash Used in Operating Activities                                                                                |   |              | (233,178                              | )       |             |   | (174,949      | )              |   |   | (655,985 | ) |
| Cash Flows Used in Investing Activities                                                                              |   |              |                                  |    |             |   |          |           |   |   |   |   |
|    Loans to affiliated companies                                                                      |   |              | (38,500                               | )       |             |   |          |           |   |   | (69,675 | ) |
| Net Cash Used in Investing Activities                                                                                |   |              | (38,500                               | )       |             |   |          |           |   |   | (69,675 | ) |
| Cash Flows Provided By (Used In) Financing Activities                                                                |   |              |                                  |    |             |   |          |           |   |   |   |   |
| Loans from related party                                                                                             |   |              | 142,310                               |    |             |   | 176,669  |           |   |   | 524,479 |   |
| Loans                                                                                                                |   |              | 130,000                               |    |             |   |          |           |   |   | 130,000 |   |
| Loan - repayment                                                                                                     |   |              | (9,500                                | )       |             |   |          |           |   |   | (9,500 | ) |
| Option exercise                                                                                                      |   |              | 5,000                                 |    |             |   |          |           |   |   | 5,000 |   |
| Issuance of common stock                                                                                             |   |              |                                  |    |             |   |          |           |   |   | 126,000 |   |
| Repayment of related party loan                                                                                      |   |              |                                  |    |             |   |          |           |   |   | (50,000 | ) |
| Net Cash Provided by Financing Activities                                                                            |   |              | 267,810                               |    |             |   | 176,669       |           |   |   | 725,979 |   |
| Net Increase (Decrease) in Cash                                                                                 |   |              | (3,868                                | )       |             |   | 1,720         |           |   |   | 319 |   |
| Cash at beginning of period                                                                                          |   |              | 4,187                                 |    |             |   | -             |           |   |   | - |   |
| Cash at end of period                                                                                                |   | $                 | 319                                   |    |             | $      | 1,720         |           |   | $ | 319 |   |
|                                                                                                                 |   |              |                                  |    |             |   |          |           |   |   |   |   |
| Supplemental Disclosures                                                                                             |   |              |                                  |    |             |   |          |           |   |   |   |   |
| Non-cash investing and financing activities                                                                          |   |              |                                  |    |             |   |          |           |   |   |   |   |
| Common stock issued in connection with:                                                                              |   |              |                                  |    |             |   |          |           |   |   |   |   |
|     Services                                                                                     |   | $                 | 517,200                               |    |             |   |          |           |   |   |   |   |
|          Acquisition of intangibles                                     |   |              |      270,000 |    |             |   |          |           |   |   |   |   |
|          Settlement of payables                                         |   |              | 5,000                                 |    |             | $      | 3,275         |           |   |   |   |   |

----

|                                                          |   |         |       |   |     |   |   |       |   |          |         |        |        |   | Deficit       |   |    |       |    |
|---------------------------------------------------------------|--------|--------------|------------|--------|----------|--------|--------|------------|--------|---------------|--------------|-------------|-------------|--------|---------------|--------|---------|------------|---------|
|                                                          |   |         |       |   |     |   |   |       |   |          |         |        | Accumulated |   | Accumulated   |   |    |       |    |
|                                                          |   |         |       |   |     |   |   | Additional |   |          |         |        | Other       |   | During        |   |    | Total      |    |
|                                                          |   | Common Stock |       |   | Paid -in |   |   | Deferred   |   | Comprehensive |         | Development |        |   | Stockholders' |   |
|                                                          |   | Shares       |       |   | Amount   |   |   | Capital    |   |          | Compensation |        | Gain        |   | Stage         |   |    | Deficiency |    |
| Shares issued to founders at $.01 per share                   |   |         | 30,000,000 |   |     | $      | 30,000 |       |   |          | -            |        |        |   | -             |   |    |       |    |   | - |   |   | $ | 30,000 |   |
| Net loss for period                                           |   |         | -          |   |     |   | -      |       |   |          | -            |        |        |   | -             |   |    |       |    | $ | (30,000 | ) |   |   | (30,000 | ) |
| Balance - December 31, 2006                                   |   |         | 30,000,000 |   |     |   | 30,000 |       |   |          | -            |        |        |   | -             |   |    |       |    |   | (30,000 | ) |   |   | - |   |
| Net loss for period                                           |   |         | -          |   |     |   | -      |       |   |          | -            |        |        |   | -             |   |    |       |    |   | (23,655 | ) |   |   | (23,655 | ) |
| Balance - December 31, 2007                                   |   |         | 30,000,000 |   |     |   | 30,000 |       |   |          | -            |        |        |   | -             |   |    |       |    |   | (53,655 | ) |   |   | (23,655 | ) |
| Shares issued at $.033 per share                              |   |         | 2,880,000  |   |     |   | 2,880  |       |   | $             | 93,120       |        |        |   | -             |   |    |       |    |   | - |   |   |   | 96,000 |   |
| Net loss for period                                           |   |         | -          |   |     |   | -      |       |   |          | -            |        |        |   | -             |   |    |       |    |   | (72,845 | ) |   |   | (72,845 | ) |
| Balance - December 31, 2008                                   |   |         | 32,880,000 |   |     |   | 32,880 |       |   |          | 93,120       |        |        |   | -             |   |    |       |    |   | (126,500 | ) |   |   | (500 | ) |
| Shares issued in settlement of payables                       |   |         | 850,000    |   |     |   | 850    |       |   |          | 27,200       |        |        |   | -             |   |    |       |    |   | - |   |   |   | 28,050 |   |
| Warrants issued inconnection with:                            |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    |       |    |   |   |   |   |   |   |   |
|   Consulting fees                                        |   |         | -          |   |     |   | -      |       |   |          | 13,450       |        |        | $      | (13,450       | )      |    |       |    |   | - |   |   |   | - |   |
|   Finance Costs                                          |   |         |       |   |     |   |   |       |   |          | 1,723,000    |        |        |   |          |   |    |       |    |   |   |   |   |   | 1,723,000 |   |
|   Indebtedness                                           |   |         |       |   |     |   |   |       |   |          | 231,537      |        |        |   |          |   |    |       |    |   |   |   |   |   | 231,537 |   |
| Amortization of deferred compensation                         |   |         | -          |   |     |   |   |       |   |          |         |        |        |   | 4,110         |   |    |       |    |   |   |   |   |   | 4,110 |   |
| Net loss for period                                           |   |         | -          |   |     |   | -      |       |   |          | -            |        |        |   | -             |   |    |       |    |   | (2,251,795 | ) |   |   | (2,251,795 | ) |
| Balance - December 31, 2009                                   |   |         | 33,730,000 |   |     |   | 33,730 |       |   |          | 2,088,307    |        |        |   | (9,340        | )      |    |       |    |   | (2,378,295 | ) |   |   | (265,598 | ) |
| Issuance of common stock in connection with:                  |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    |       |    |   |   |   |   |   |   |   |
|   Exercise of warrants                                   |   |         | 500,000    |   |     |   | 500    |       |   |          | 4,500        |        |        |   |          |   |    |       |    |   |   |   |   |   | 5,000 |   |
|   Indebtedness                                      |   |         | 40,000     |   |     |   | 40     |       |   |          | 35,960       |        |        |   |          |   |    |       |    |   |   |   |   |   | 36,000 |   |
|  Services - Board                                        |   |         | 250,000    |   |     |   | 250    |       |   |          | 132,250      |        |        |   |          |   |    |       |    |   |   |   |   |   | 132,500 |   |
|  Services – other                                  |   |         | 675,000    |   |     |   | 675    |       |   |          | 384,025      |        |        |   |          |   |    |       |    |   |   |   |   |   | 384,700 |   |
|  Acquisition of   intangibles             |   |         | 300,000    |   |     |   | 300    |       |   |          | 269,700      |        |        |   |          |   |    |       |    |   |   |   |   |   | 270,000 |   |
| Issuance of options    Board and officers |   |         |       |   |     |   |   |       |   |          | 1,245,313    |        |        |   |          |   |    |       |    |   |   |   |   |   | 1,245,313 |   |
| Consulting fees                                               |   |         |       |   |     |   |   |       |   |          | 388,537      |        |        |   |          |   |    |       |    |   |   |   |   |   | 388,537 |   |
| Amortization of deferred  compensation              |   |         |       |   |     |   |   |       |   |          |         |        |        |   | 9,340         |   |    |       |    |   |   |   |   |   | 9,340 |   |
| Net loss for period                                           |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    |       |    |   | (2,521,606 | ) |   |   | (2,521,606 | ) |
| Unrealized loss on  Investments                     |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    | (120,000   | )  |   |   |   |   |   | (120,000 | )  |
| Total comprehensive loss                                      |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    |       |    |   |   |   |   |   | (2,641,606 | ) |
| Balance – September 30, 2010                            |   |         | 35,495,000 |   |     | $      | 35,495 |       |   | $             | 4,548,592    |        |        | $      | -             |   | $  | (120,000   | )       | $ | (4,899,901 | ) |   | $ | (435,814 | ) |
|                                                          |   |         |       |   |     |   |   |       |   |          |         |        |        |   |          |   |    |       |    |   |   |   |   |   |   |   |

----

|                                                                                                                                                                |   | Three Months Ended |     |   | Nine Months Ended |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------|----------|--------|-------------------|--------|
|                                                                                                                                                                |   | September 30, 2009 |     |
|    Net increase in net assets resulting from                                                                                                         |   |               |     |   |              |   |
|             operations – as reported                                                              |   | $                  | 250,244  |   |              | $      | 165,408 |   |
|    Less: unrealized gains on investments                                                                                                             |   |               | (899,170 | )      |              |   | (899,170 | ) |
|    Net loss – as restated                                                                                                                      |   | $                  | (648,926 | )      |              | $      | (733,762 | ) |
|                                                                                                                                                                |   |               |     |   |              |   |   |   |
|    Net income per share – basic and dilutive – as reported              |   | $                  | 0.01     |   |              | $      | 0.01 |   |
|    Net loss per share – basic and dilutive – as restated                                                                                 |   | $                  | 0.02     |   |              | $      | 0.02 |   |

----

----

| Advances:        |   |   |    |
|------------------|--------|--------|---------|
| Loans            |   | $      | 65,000  |   |
| Management fees  |   |   | 30,000  |   |
| Interest         |   |   | 4,000   |   |
| Equity in losses |   |   | (17,000 | ) |
|             |   | $      | 82,000  |   |

| License for “Insect Repellent Composition Containing Essential Oils” – see Note 3 above    |   | $      | 82,000  |   |
|--------------------------------------------------------------------------------------------------------------|--------|--------|---------|--------|
| License for an oral spray technology for delivery of medications through the buccal mucosa – see below |   |   | 270,000 |   |
| Total                                                                                                        |   | $      | 352,000 |   |

----

| Investor relations firm                                         |   | $      | 80,300  |   |
|-----------------------------------------------------------------|--------|--------|---------|--------|
| Debt holder – penalty for payment not made – Note 6 |   |   | 24,400  |   |
| Settlement – for services rendered                        |   |   | 1,558   |   |
|                                                            |   | $      | 106,258 |   |

----

| Expected volatility   |   |   | 100    | % |
|-----------------------|--------|--------|--------|---|
| Expected dividends    |   |   | 0      | % |
| Expected term         |   | 5years |   |
| Risk-free rate   |   |   | 2.36   | % |

----

| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|--------------|----------------------------------------------------------------------------------------------|

|                                                                                                                                                                |   | Three Months Ended |     |   | Nine Months Ended |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------|----------|--------|-------------------|--------|
|                                                                                                                                                                |   | September 30, 2009 |     |
|    Net increase in net assets resulting from                                                                                                         |   |               |     |   |              |   |
|             operations – as reported                                                              |   | $                  | 250,244  |   |              | $      | 165,408 |   |
|    Less: unrealized gains on investments                                                                                                             |   |               | (899,170 | )      |              |   | (899,170 | ) |
|    Net loss – as restated                                                                                                                      |   | $                  | (648,926 | )      |              | $      | (733,762 | ) |
|                                                                                                                                                                |   |               |     |   |              |   |   |   |
|    Net income per share – basic and dilutive – as reported              |   | $                  | 0.01     |   |              | $      | 0.01 |   |
|    Net loss per share – basic and dilutive – as restated                                                                                 |   | $                  | 0.02     |   |              | $      | 0.02 |   |

----

----

----

----

| 31.1   |   | Certification of Chief Executive Officer                                          |
|--------|--------|-----------------------------------------------------------------------------------|
|   |   |
| 31.2   |   | Certification of Chief Financial Officer                                          |
|   |   |
| 32.1   |   | Section 1350 Certification of Chief Executive Officer and Chief Financial Officer |

----

|   | Spring Creek Healthcare Systems, Inc. |                                 |
|--------|---------------------------------------|--------------------------------------|
|   |                                  |                                 |   |
|   | By:                                   | /s/ Kelly T. Hickel   |   |
|   |                                  | Kelly T. Hickel                      |   |
|   |                                  | Chief Executive Officer              |   |
|   |                                  |                                 |   |
|   |                                  |                                 |
|   |                                  |                                 |   |
|   | By:                                   | /s/ Jan E. Chason          |   |
|   |                                  | Jan E. Chason                        |   |
|   |                                  | Chief Financial Officer              |   |
|   |                                  |                                 |   |